Tyler G. Saint-Denis, Ru-Yi Zhu, Gang Chen, Qing-Feng Wu, Jin-Quan Yu* BACKGROUND: The ultimate goal of synthetic chemistry is the efficient assembly of molecules from readily available starting materials with minimal waste generation. The synthesis of organic molecules-compounds containing multiple carbon-hydrogen (C-H) and carbonheteroatom (such as oxygen or nitrogen) bondshas greatly improved our quality of life. Pharmaceuticals that can treat disease, agrochemicals that enhance crop yields, and materials used in computer engineering are but three illustrative examples. And yet more often than not, the syntheses of these substances have proved challenging because of restrictions on how molecules can be constructed.
Major advances in organic chemistry have relied on the discovery of reactions that dramatically altered chemists' approach to building molecules. Canonical organic reactions typically rely on the high reactivity of functional groups (with respect to a C-H bond) in order to introduce new functionality in a target molecule. However, there are times when the accessibility of certain functional groups at particular carbon centers may be restricted; in these cases, the installation of functionality may require several steps and can lead to undesired side reactions, delaying the production of as well as decreasing the overall yield of a synthetic target.
Considering that organic molecules possess an abundance of C-H bonds, it should be unsurprising that C-H functionalization (the conversion of C-H bonds into C-X bonds, where X ≠ H) has garnered considerable attention as a technique that could alter synthetic organic chemistry by enabling relatively unreactive C-H bonds to be viewed as dormant functionality.
And yet, to date applications of C-H functionalization logic are hindered by considerable limitations in terms of regioselectivity and stereoselectivity (the construction of chiral centers).
ADVANCES: Although numerous approaches to regioselective C-H functionalization have been extensively reported, only recently has attention been placed on addressing the issues of stereoselectivity. One such solution entails chiral transition metal catalysts in which a metal complexed to a chiral ligand reacts directly with a C-H bond, forming a chiral organometallic intermediate that is then diversely functionalized. A variety of transition metal catalysts have been shown to affect the asymmetric metallation of C-H bonds of enantiotopic carbons (C-H bonds on different carbons) or enantiotopic protons (C-H bonds on the same carbon). The major driving force behind the development of enantioselective C-H activation has been the design of chiral ligands that bind to transition metals, creating a reactive chiral catalyst while also increasing the reactivity at the metal center, accelerating the rate of C-H activation.
OUTLOOK: In order for enantioselective C-H activation to become a standard disconnection in asymmetric syntheses, the efficiency of catalyses and breadth of transformations must be improved. Although the specific requirements to achieve these goals are unclear, we argue that improved ligand design will be instrumental to further progress until any C-H bond of any molecule can be converted into any functionality in high yields with high enantioselectivity. The impact of such progress will no doubt have rippling effects in seemingly disparate fields, such as medicine, by enabling the syntheses of previously inaccessible forms of matter.
O ne of the long-standing objectives of organic chemistry is the selective functionalization of carbon-hydrogen (C-H) bonds (1). This is because organic molecules consist of carbon frameworks (occasionally containing heteroatoms such as oxygen, nitrogen, and sulfur) bearing hydrogen atoms on the majority of carbon centers. Traditionally, the synthetic manipulations possible in organic synthesis have been limited by the availability of distinct functional groups at specific carbon centers; consequently, synthetic transformations are not possible at the majority of carbon centers containing inert C-H bonds. Such limitations have often forced synthetic chemists to pursue indirect, multistep manipulations to introduce functionality in a reaction sequence, and have restricted the use of simple starting materials in synthetic endeavors.
The intrigue of C-H functionalization in the synthesis of complex synthetic targets thus stems from the potential to view inert C-H bonds as masked reactive functionalities, which may be unlocked by a reagent under the appropriate reaction conditions. By virtue of the abundance of C-H bonds in organic molecules, C-H bond functionalization, in principle, could allow structural modification at any carbon center of an organic molecule, altering synthetic chemistry's modus operandi by shortening synthetic routes, increasing atom and step economy, enabling novel disconnections, and expediting the production of target molecules. Further, in the arenas of drug discovery and drug design C-H functionalization may allow chemists to take relatively complicated molecules and in a single step introduce a diverse range of functionalities to previously inaccessible carbon centers so as to afford analogs with potentially improved biological properties.
The greatest hindrance to the widespread application of C-H activation is selectivity: In molecules with multiple C-H bonds of comparable bond strengths and steric environments, it has been traditionally difficult to control chemo-, regio-, and stereoselectivity in C-H activation processes. Although recent advances have been made in the regioselective metalation of both proximal and remote C-H bonds by using directing effects or electronic biases by several different groups (2-4), practical stereoselective C-H activation has received considerably less attention. The lack of attention toward enantioselective C-H activation is striking, given the paramount importance of chirality in organic molecules; for example, pharmaceuticals often require chiral components, owing to the inherent chirality of life (5) . The development of such enantioselective C-H activation methodologies would make it possible to precisely modify C-H bonds and generate new stereocenters in a single step, providing synthetic chemists with the power to specify where, what, and when stereocenters are introduced in a reaction sequence.
To date, several different approaches have been developed to enantioselectively modify C-H bonds (Fig. 1) . These include biomimetic approaches (6), akin to the H-atom abstraction of cytochrome P450 (7), as well as other enzymatic processes (metal-oxo H-atom abstractions) (Fig. 1A) (8, 9) ; metallonitrene (10) and metallocarbene (11, 12) insertions (Fig. 1B) ; and transition metal-mediated C-H activation (Fig. 1C) (13) , which is typified by a C-H cleavage event preceding generation of a wellcharacterized carbon-metal bond and is the topic of this Review (14, 15) . Two main methods have emerged for this latter approach, including desymmetrizing C-H activation [such as isopropyl desymmetrization, in which the chiral carbon center is not bound to the transition metal (Fig. 1C) ] and transition metal complex recognition of enantiotopic methylene C-H bonds [in which the chiral carbon center is bound to the transition metal (Fig. 1C) ]. Further, C-H activation-based kinetic resolution of racemic (a one-to-one ratio of enantiomers) substrates has been demonstrated and is an active area of research (Fig. 1C) . Transition metal-catalyzed C-H activation has largely been enabled by select catalytic cycles, including palladium (Pd)(II/0), Pd(II/IV), Pd(0/II), Pd(II/II), and rhodium (Rh) or iridium (Ir)(I/III), although other preliminary examples do exist (16) . Here, we highlight recent major achievements (Fig. 1D ) in the development of enantioselective C-H bond activation, with an emphasis on stereochemistry-generating C-H activation (as opposed to enantioselection occurring in other non-C-H activation steps) and the design of chiral ligands and stereomodels to enable these technologies. For a comprehensive review covering enantioselective C(sp 
Enantioselective C-H activation through desymmetrization
Enantioselective desymmetrization C-H activation reactions primarily fall into two categories: the desymmetrization around a point (a single atom) in a substrate and the desymmetrization of a plane or axis of a substrate, exemplified by the desymmetrization of metallocene compounds (17, 18) and atroposelective C-H activation (19) , respectively. That said, because planar and axial desymmetrization do not encompass C(sp 3 )-H activation, the corresponding stereomodels will not be discussed here. Enantioselective C-H point desymmetrization involves the generation of a stereocenter either distal (more than two bonds away) to the C-H bond undergoing activation, as is the case with C(sp 2 )-H desymmetrization, or adjacent (two bonds away/vicinal) to a C(sp 3 )-H bond undergoing activation ( Fig. 2A) . These examples are in contrast to methylene C-H activation, in which the newly formed stereocenter is on the same carbon of the C-H bond that was functionalized (Enantioselective methylene C-H activation, below). The earliest examples of enantioselective catalytic C-H activation relied on the use of mono-N-protected amino acid (MPAA) ligands to desymmetrize pyridinecontaining substrates by means of Pd(II)/Pd(0) catalysis (20) . This work exploited the wellestablished directing group (DG) nature of pyridine (21) in order to direct palladation of both C(sp 2 )-H and C(sp )-H bonds as well as chiral carboxylates in order to induce asymmetric cyclopalladation. MPAA ligands were investigated given their easy preparation from commercially available and naturally occurring amino acids as well as their ability to coordinate Pd(II) and serve as chiral carboxylate surrogates, as originally proposed by Sokolov et al. (22) , or as bidentate ancillary ligands, as studied by Navarro et al. (23) (Fig. 3A) . Initial stoichiometric studies with Pd(OAc) 2 yielded a racemic cyclometallated dimer in 85% yield (Fig. 3A) , and it was proposed that replacing the bridging acetates with amino acid ligands would lead to the formation of a chiral cyclometallated dimer; however, thorough variation in amino acid substitution elucidated a different mechanism for stereocontrol: Unprotected leucine amino acids (entry 1) suppressed catalysis and double N-protected amino acids (entry 2)-though affording product in high yield-gave minimal stereocontol [7% enantiomeric excess (ee)]. Mono-N-protection was critical for both yield and enantiocontrol (entry 3, 90% ee), and conversion of the carboxylate to the corresponding methyl ester (entry 4) afforded racemic product in 86% yield. Entries 2, 3, and 4 suggest that the operative mechanism of enantiocontrol induced by MPAAs relies on bidentate coordination by both the carboxylate and the mono-protected amine to the metal center. Although bidentate cyclopropyl MPAA (entry 5) was capable of moderate enantiocontrol and yield, the C 2 -symmetric bidentate cyclopropyl MPAA (entry 6) only afforded racemic product. This was a surprising and important finding, given the dominance of C 2 -symmetric ligands in transition metal catalysis (24) and suggested that a radically different ligand architecture would be needed to effectively induce stereocontrol in C-H activation (monodentate C 2 ligands are discussed later). Further optimization of ligand design yielded the (-)-menthol derivative of leucine (entry 7) as the most effective ligand. 1 H nuclear magnetic resonance, mass spectroscopy, and density functional theory computational studies elucidated the mechanism of stereoinduction in these reactions (25) and have led to the proposal of a stereomodel that is consistent with the reactivity and stereochemistry observed in this reaction as well as the necessary requirements (Fig. 3B) . The pretransition state intermediate, in which Pd is bound both to the MPAA ligand as well as the directing group of the substrate, may proceed through two distinct pathways: In the disfavored pathway (S), it is proposed that a high-energy transition state is formed in which there is steric clashing between the bulky chain of the MPAA ligand and a large aryl group of the substrate; in the favored pathway (R), this steric clashing is avoided, resulting in a lower-energy transition state and thus the major product. The original report of MPAA ligands for enantioselective C-H activation also disclosed the enantioselective C(sp 3 )-H activation of 2-isopropyl pyridine (Fig. 3C) (19) ; however, both the yield and the ee reported were low (38 and 37%, respectively). One reason the alkyl substrate has such poor selectivity may be that the catalyst has to differentiate between a methyl group and a hydrogen atom, which are relatively close in size compared with the differentiation required in Fig. 3B (between an aryl group and a hydrogen atom). Additionally, pyridine-directed C-H activation persisted in the absence of chiral ligand (a racemic background reaction proceeds). This example underscores two substantial pitfalls of conventional directed C-H activation: Typically, innate functionality (carboxylic acids, amines, alcohols, and ethers) fails to interact sufficiently with a transition metal catalyst to direct metallation, so that strong directing groups must be installed before C-H activation so as to effectively direct metallation. When strong directing groups (such as pyridine or 8-amino quinoline) (Fig. 4B ) are present in a substrate, the substrate may outcompete ligand binding to a transition metal center (substrate is usually an order of magnitude greater in concentration than ligand) and/or undergo a reaction in the absence of a chiral ligand, affording racemic product (Fig. 4A) . Moreover, strong directing groups may lead to a thermodynamically stable cyclopalladation intermediate, hindering subsequent functionalization steps.
These so-called background reactions are detrimental to enantiocontrol; one solution to this problem has been the use of weakly coordinating monodentate directing groups (26) , which ideally in the absence of a chiral bidentate ligand fail to afford any product. The key principles of ligand design for enantioselective C-H activation reaction are thus twofold; ligands must both be capable of creating a steric environment that affords stereocontrol and must increase reactivity of a transition metal catalyst, accelerating the rate of the reaction.
Fortunately, it was discovered early on that MPAAs are capable of dramatically accelerating a wide variety of C-H activation transformations (27, 28) . This discovery, compounded with the facile syntheses of diverse MPAAs, motivated the use of MPAA ligands in the presence of weakly coordinating monodentate directing groups for the desymmetrization of cyclopropyl and cyclobutyl compounds by using Pd(II)/Pd(0) catalysis (Fig. 5A) (29, 30) . Cyclopropyl and cyclobutyl compounds were chosen as substrates because the requisite C(sp )-H bonds and because these rigid systems would allow for precise elucidation of the mechanism of stereoinduction. Because of the conformation of the substrates, only single cis-diastereomers were observed, and through fine-tuning of MPAA ligand side chain and N-protecting group, enantioselective crosscoupling of cyclopropyl compounds could be achieved in up to 70% yield with up to 94% ee (29) . Further modification of MPAA ligand side chain to a 2,6-diarylated phenyl compound as well as conversion of the carboxylate to an Nhydroxamic ester (Fig. 5A ) allowed for the desymmetrization of cyclobutyl compounds in up to 77% yield as well as 95% ee (Fig. 5A) (30) . The stereomodels proposed to rationalize stereochemical induction in these systems (Fig. 5A) are based on computational studies (31) as well as assignment of the absolute configuration; in both cases, it is believed that the repulsive interaction between the sterically bulky N-protecting group and the large MPAA side chain forces the MPAA side chain to be orthogonal to the square plane of Pd(II), and that the rigid position of the MPAA side chain also forces the substrate cyclobutane orthogonal to the square plane and trans to the MPAA side chain, in order to avoid unfavorable steric clashing as shown in the disfavored intermediate (Fig. 5A ). These models have also proven reliable in rationalizing enantioinduc- )-H bond and the to-be-installed functionality are linked by a covalent tether]; because of the rigidity imparted by intramolecularity, C 2 -symmetric ligands have had success in these catalytic arenas. In the Pd(0)/Pd(II) systems, oxidative addition by Pd(0) to substrate aryl-iodides, -bromides, or -triflates generates a Pd(II) intermediate that then proceeds to cleave an intramolecular C(sp 3 )-H bond (Fig. 5B) . In this regard, the aryl-iodide, -bromide, or -triflate serves as a pseudo-directing group, but one that is consumed during the course of the reaction; the aryl-iodide, -bromide, or -triflate both relay chiral transition metal catalysts to a target C-H bond and serve as the source of functionality installed during a reaction.
These catalytic regimes are capable of desymmetrizing gem-dimethyl substrates, as well as cyclic substrates with high ee (up to 93 and 95%, respectively). Preliminary studies to elucidate the role of ligand in the stereochemical outcomes of these reactions have been performed (41, 42) ; in almost all cases, the ligands required to enable reactivity and enantioselectivity are monodentate phosphines, phosphoramidites, or N-heterocyclic carbenes (NHCs), which enable Pd(0) to oxidatively add to substrates, although a single example of the bidentate phosphine (R,R)-Me-DUPHOS imparting enantioselectivity has been reported (35) . In the few examples of enantioselective Rh(I)/Rh(III) C(sp 3 )-H activation, bidentate C 2 -symmetric ligands have afforded enantioenriched products (Fig. 5C) (38, 39) ; the most notable example by Hartwig entails the twostep sequence of in situ alcohol protection of cyclopropylmethyl alcohols to the corresponding alkoxysilane, followed by intramolecular C-H cyclization (up to 90% yield and up to 90% ee) (38) . A similar strategy by use of Ir(I) catalysis in the presence of an N,N-bidentate chiral ligand enabled intramolecular Si-C bond formation in acyclic systems (Fig. 5C) (40) . The stereomodels for these Rh(I)/Ir(I)-catalyzed reactions remain to be established, and the precise enantiocontrol imparted by C 2 -symmetric/C 2 -symmetric-derived ligands is currently under rigorous investigation.
The majority of C(sp of acyclic systems (gem-dimethyl groups) by using the above methodologies were reported (29, 39, 40) ; however, yields and enantioselectivities are generally poor for intermolecular desymmetrization of acyclic systems (Figs. 3C and 6A). These results highlight two major challenges of C-H activation enantioinduction of acyclic systems: In cyclic systems, hydrogen atoms and target C-H bonds have restricted rotational freedom and, consequently, restricted conformations; acyclic systems possess many more accessible conformational states. Furthermore, in acyclic systems a catalyst must sterically distinguish relatively similar methyl groups and hydrogen atoms, as opposed to the target C-H bond and the conformationally locked remainder of a cyclic molecule (Fig. 6A) . Insofar as the relevance of gem-dimethyl desymmetrization is concerned, one of the most important biological pathways used in the synthesis of myriad natural products entails the enzyme-catalyzed enantioselective hydroxylation of isobutyric acid (43). Our group engineered a ligand that could enable an analogous transformation-namely, the robust Pd(II)/ Pd(IV)-catalyzed desymmetrization of isobutyramides. Inspired by our previous work on the diastereoselective iodination of a-dialkyl groups enabled by a chiral oxazoline auxiliary (Fig. 6B ) (44) , as well as the bidentate coordination mode of mono-N-protected amino acids, we synthesized bidentate N-acetyl-protected aminomethyl chiral oxazoline (APAO) ligands, which were capable of enantioselective arylation, alkenylation, and alkynylation of isobutyramides in moderate yields with high enantioselectivities (Fig. 6C) (45) . Because the original report of APAO ligands, they have also been exploited for the enantioselective borylation of cyclic amide substrates enabled by Pd(II)/Pd(0) chemistry (46) . The proposed stereomodel rationalizing the general high enantioselectivity imparted by the APAO ligands (Fig. 6D) orients the bulky phenyl substituent on the oxazoline ring and the tert-butyl group side chain perpendicular to the square plane of Pd(II) in such a way as to evade steric clashing; the tertbutyl group then forces the N-acetyl group into the square plane of Pd(II), engaging with the target C-H bond. In the disfavored C-H cleavage transition state, the methyl group of the substrate has intense steric clashing with the phenyl substituent of the APAO ligand; in the favored C-H cleavage transition state, this interaction is avoided by positioning of the methyl trans to the sterically encumbering phenyl group. This preliminary stereomodel has yet to be validated and is under computational investigation. The generality of transformations enabled by APAO ligands [including Pd(II)/Pd(IV) and Pd(II)/Pd(0) catalyses] parallels that of MPAA ligands. Further, the ease by which these ligands may be diversely prepared as well as the success so far reported in the steric differentiation of a hydrogen atom and a relatively small methyl group will no doubt provide invaluable insight for the further development of desymmetrizing enantioselective C-H activation.
Enantioselective methylene C-H activation
The C-H activation of methylene (secondary) enantiotopic C-H bonds is a synthetic challenge for two main reasons: First, secondary C-H bonds are substantially less stereoelectronically prone to C-H cleavage/C-H insertion than their primary counterparts because they are both less sterically accessible (kinetic) and possess greater heterolytic bond dissociation energies (thermodynamic).
There are several examples of enantioselective point-desymmetrization (presented above) on methylene C-H bonds; however, these do not entail the chiral differentiation of enantiotopic methylene C-H bonds but rather entail the desymmetrization of enantiotopic carbons because only the syn-product can be formed. Moreover, cyclopropane and cyclobutane C-H bonds possess electronic properties comparable with those of aromatic C-H bonds, therefore making these C-H bonds more reactive (47) . In terms of stereochemical induction in methylene C-H activation of acyclic substrates, a catalyst must be capable of differentiating a relatively small hydrogen atom and a relatively large R-group (Fig. 7A) ; as the size of this R-group decreases, catalyst differentiation of the hydrogen and R-group becomes increasingly difficult. Despite these challenges, substantial progress has been made in enantioselective methylene C-H activation; at present, there are three different substrate categories in directed enantioselective methylene C-H activation (Fig. 7A) , including C-H bonds a-to-heteroatom, benzylic C-H bonds, and unbiased methylene C-H bonds of linear systems. The majority of methylene C-H activation reactions have been of the first two categories, and various transition metal catalysts and ligands have enabled these reactions. For example, enantioselective Ir(I)/Ir(III)-catalyzed alkylation/olefination of methylene C-H bonds adjacent to nitrogen atoms has been reported in both acyclic and cyclic substrates, affording products in high yield and high ee (Fig. 7B, equation 1)  (48-50) . Mechanistically, the target methylene C-H bond undergoes oxidative addition to an Ir(I) catalyst ligated with a C 2 -symmetric bidentate phosphine ligand, and the requisite organometallic intermediate then undergoes insertion into olefins or alkynes, affording the alkylated and alkenylated species, respectively. In all of these cases, a precise stereomodel has 5 of 12 yet to be proposed so as to rationalize stereochemical induction, and as seen above in desymmetrization C-H activation, the role of bidentate C 2 -symmetric ligands in imparting stereochemical induction is not well defined, and the hemilabile nature of bidentate phosphines may need to be invoked. Monodentate C 2 -symmetric phosphoramidites (51) and phosphoric acid (52) ligands have been shown to enable Pd(0)-catalyzed intramolecular cyclization and Pd(II)-catalyzed intermolecular arylation of a-methylene C-H bonds, respectively (Fig. 7B, equation 2) . Although the yields and enantioselectivities of these reactions are high, the corresponding stereomodels are ambiguous and under investigation. For enantioselective benzylic methylene C-H activation, two distinct approaches have been reported. The first was inspired by the highly enantioselective C-H desymmetrization imparted by amino acid-derived ligands. Our group developed a transient chiral auxiliary approach for enantioselective benzylic methylene C-H activation of 2-alkyl benzaldehyde substrates in which the chiral element is covalently attached to the substrate before the chiral induction step (Fig. 7C state, which proceeds to form product; were the intermediate to adopt a cis-conformation (highly disfavored), the opposite enantiomer would be favored.
The second approach to benzylic methylene C-H activation (Fig. 7C, equation 4) has relied on strong bidentate directing groups and monodentate chiral C 2 -symmetric phosphoramidites/ phosphoric acids (54, 55) . The yields and enantioselectivites of these reactions are moderate to good, and the shortcomings of these approaches may be attributed to the strongly coordinating attempts to adopt this approach for electronically unbiased (nonbenzylic) substrates; both yields and enantioselectivities were low, suggesting that substrate-driven cyclopalladation is a major hindrance to high enantioselectivity ( Fig. 8A ) (54) . Our group was motivated by our previous successes in the use of monodentate weakly coordinating directing groups/bidentate chiral ligands for enantioselective C(sp 3 )-H activation. Inspired by previous reports of monodentate quinoline-enabled Pd(II)-catalyzed racemic methylene C-H activation as well as the privileged structure of bidentate MPAA ligands (Fig.  8B ) (56), we began a campaign on the synthesis of chiral bidentate quinoline-based ligands (57) .
Extensive ligand design revealed that an acetylprotected aminoethyl quinoline (APAQ) ligand not only enabled Pd(II)-catalyzed methylene C-H arylation to proceed with a weak directing group but also to afford the corresponding products with high enantioselectivity (Fig. 8C) . Systematic ligand modification revealed that sixmembered chelation was critical for reactivity (the corresponding five-membered chelating quinoline/acetyl-protected amine ligands failed to afford any product) and that cis-substitution was necessary for high reactivity as well as enantioselectivity; the corresponding diastereomeric ligands failed to afford the desired product in reasonable yields or enantioselectivities. The best ligand for this reaction (Fig. 8C) contains both a bulky 3,5-di tert-butyl phenyl group at C1 and an ethyl group at C2. The stereochemical induction imparted by APAQ ligands has been the subject of computational studies (57, 58) , and the proposed stereomodel of APAQ-enabled enantioselective methylene C-H activation is shown in Fig. 8D . In the favored transition state, the combined action of the sterically encumbering 3,5-di-tertbutyl phenyl of the ligand and the bulky directing group of the substrate is believed to force the quinoline portion of the APAQ ligand perpendicular to the square plane of Pd(II), which in turn forces the bulky R-group of the substrate to orient itself trans to the quinoline. In the RESEARCH | REVIEW disfavored transition state, the perpendicular quinoline has an intense steric interaction with the cis-situated R-group of the substrate. Although substitution at the C2 position of the APAQ ligands is not a prerequisite for high reactivity (57), it is believed that the ethyl group shown in the competing transition states of Fig. 8D helps orient the 3,5-di-tert-butyl phenyl group to force the quinoline to adopt a geometry perpendicular to the square planar of Pd(II), affording high enantiocontrol. The breadth of methylene C-H bonds that may be enantioselectively functionalized by APAQ-ligated Pd(II) will no doubt provide invaluable insight for the development of new ligand classes for enantioselective methylene C-H activation on diverse substrates involving both different redox catalytic cycles as well as transformations.
Kinetic resolution
The discussions above on point desymmetrization C(sp 3 )-H activation and enantioselective methylene C(sp )-H activation routes via kinetic resolution. Parallel kinetic resolution has been reported for the regiodivergent synthesis of indolines from racemic carbamates (Fig. 9C and Eq. 1) (64) . In this reaction, each enantiomer proceeds to form different constitutional isomers. This reaction was enabled with a monodentate C 2 -symmetric NHC ligand, and it is believed that the active chiral catalyst forms diastereomeric intermediates when binding with each enantiomer of the starting material and that these diastereomeric intermediates proceed to different products. A single example of kinetic resolution of C(sp 3 )-H bonds was recently reported by using intramolecular Pd(0)/Pd(II) catalysis and chiral phosphate ligands, although yield and ee were low (Fig. 9C,  equation 2 ) (65). To date, intermolecular kinetic resolution through C-H activation of methylene C(sp 3 )-H bonds or point desymmetrization has yet to be reported; through rigorous catalyst and ligand design, such synthetically useful processes will likely reach fruition.
Conclusion
In the past century, asymmetric catalysis has dramatically changed the way chemists construct chiral molecules and has made the synthesis of various pharmaceuticals, agrochemicals, pesticides, materials, and natural products possible (66, 67) . Moreover, rationalization of chiral induction in asymmetric catalysis has been one of the most powerful tools to elucidate molecular mechanisms of these reactions and has contributed substantially to our understanding of the underpinnings of catalysis (68) . Enantioselective C-H activation is currently emerging as a new avenue for developing asymmetric catalysis, and the interest it has garnered, both academic and industrial, has grown enormously over the past decade. The examples of enantioselective C(sp 3 )-H activation presented here should attest to this growth and underscore the promise this field holds to enrich synthetic disconnections, expedite chemists' endeavors to make synthetic targets, construct chiral molecules from simple feedstock chemicals, and elucidate various mechanisms of organometallic processes, providing guidance for the development of superior chiral catalysts. Although the field of enantioselective C(sp 3 )-H activation by means of chiral transition metal catalysts is young, the breadth of substrates, transformations, catalyses, and ligand platforms involved in these reactions is impressive and will continue to expand. No doubt the field will continue to grow and overcome current limitations, such as scope and reactivity, until any C-H bond of any molecule can be converted into any C-X bond with high yield, regiocontrol, and enantioselectivity. Most importantly, however, is that this growth may have tremendous impact on seemingly disparate fields by enabling the synthesis of hitherto inaccessible forms of organic matter.
